Obstetrics, gynecology and reproductive medicine guidelines

Female genital neoplasms

PubMed Free Full Text

Cervical cancer: vaccine

 

America

• Centers for Disease Control and Prevention
  • Progress Toward Implementation of Human Papillomavirus Vaccination --- the Americas, 2006--2010 [2011]

Australia

• Australian Family Physician
  • Abnormal Pap tests after the HPV vaccine [2009]

• Australian Institute of Health and Welfare
  • HPV immunisation rates 2015–16 [2018]

• Australian Journal of General Practice
  • Human papillomavirus vaccination update: Nonavalent vaccine and the two-dose schedule [2018]

• Department of Health Australia
  • Human papillomavirus (HPV) | The Australian Immunisation Handbook [2018]

• EuroSurveillance
  • The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent? [2018]

• Lancet Public Health
  • Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis [2016]

• PLoS ONE
  • Projected future impact of HPV vaccination and primary HPV screening on cervical cancer rates from 2017–2035: Example from Australia [2018]

Austria

• BMC Infectious Diseases
  • Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria [2016]

Botswana

• Centers for Disease Control and Prevention
  • Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project — Botswana, 2013 [2015]

Brazil

• Revista Panamericana de Salud Pública
  • Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign [2015]

Canada

• BMC Infectious Diseases
  • Canadian oncogenic human papillomavirus cervical infection prevalence: Systematic review and meta-analysis [2011]

• Canadian Family Physician
  • Effect of human papillomavirus vaccination on sexual behaviour among young females [2018]
  • Update on the new 9-valent vaccine for human papillomavirus prevention [2016]
  • HPV vaccine for cancer and wart prevention [2015]

• Canadian Paediatric Society
  • Human papillomavirus vaccine for children and adolescents [2018]

• Government of Canada
  • Human Papillomavirus Vaccine

• Public Health Agency of Canada
  • Updated Recommendations on Human Papillomavirus Vaccines: 9-valent HPV vaccine and clarification of minimum intervals between doses in the HPV immunization schedule [2016]
  • Update On Human Papillomavirus (HPV) Vaccines [2012]

• Public Health Ontario
  • Human Papillomavirus Vaccine: Technical Report [2017]

Chile

• BMC Public Health
  • Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model [2014]

China

• BMC Infectious Diseases
  • Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China [2017]

• BMC Public Health
  • Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies [2016]

Developing countries

• Infectious Diseases in Obstetrics and Gynecology
  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries [2011]

Estonia

• BMC Infectious Diseases
  • The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia [2013]

Europe

• Cancer Medicine
  • HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level [2019]

• European Society of Gynaecological Oncology
  • Human papillomavirus vaccination: The ESGO–EFC position paper of the European society of Gynaecologic Oncology and the European Federation for colposcopy [2019]

• WHO Regional Office for Europe
  • Preparing for the introduction of HPV vaccine in the WHO European Region [2008]
  • Strengthening cervical cancer prevention in Europe [2007]
  • Can we prevent cervical cancer? [2007]

Fiji

• BMC Public Health
  • Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents [2015]

France

• Human Vaccines & Immunotherapeutics
  • Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history [2015]
  • A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France [2013]

High-income countries

• BMC Public Health
  • Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis [2014]

Hong Kong

• PLoS ONE
  • Uptake of human papillomavirus (HPV) vaccination in Hong Kong: Facilitators and barriers among adolescent girls and their parents [2018]

India

• ISRN Obstetrics and Gynecology
  • HPV Vaccination in India: Critical Appraisal [2014]

International

• American Society of Clinical Oncology
  • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline [2017]

• Bulletin of the World Health Organization
  • Delivery cost of human papillomavirus vaccination of young adolescent girls in Peru, Uganda and Viet Nam [2013]
  • Human papillomavirus and HPV vaccines: a review [2007]
  • Ensuring access to HPV vaccines through integrated services: a reproductive health perspective [2007]

Ireland

• Health Protection Surveillance Centre
  • HPV

• Ireland's Health Services
  • Human Papillomavirus [2016]

Low and middle-income countries

• BMC Health Services Research
  • Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014 [2016]

• Vaccine
  • Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects [2013]

Luxembourg

• Cancer Epidemiology
  • Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg [2019]

Malaysia

• BMC Public Health
  • Cost- effectiveness of HPV vaccination regime: comparing twice versus thrice vaccinations dose regime among adolescent girls in Malaysia [2016]

Middle East, North Africa

• Eastern Mediterranean Health Journal
  • Knowledge, awareness and acceptability of anti-HPV vaccine in the Arab states of the Middle East and North Africa Region: a systematic review [2018]

New Zealand

• Ministry of Health New Zealand
  • Revitalising the National HPV Immunisation Programme [2015]
  • HPV Immunisation Programme Implementation Evaluation [2012]

Nigeria

• BMC Health Services Research
  • Cost-effectiveness of Human Papilloma Virus (HPV) vaccination in Nigeria: a decision analysis using pragmatic parameter estimates for cost and programme coverage [2017]

Norway

• PLoS ONE
  • Prevention of HPV-Related Cancers in Norway: Cost-Effectiveness of Expanding the HPV Vaccination Program to Include Pre-Adolescent Boys [2014]

• Preventive Medicine
  • Correlates of HPV vaccine uptake in school-based routine vaccination of preadolescent girls in Norway: A register-based study of 90,000 girls and their parents [2015]

Peru

• PLoS ONE
  • Parental Acceptance of HPV Vaccine in Peru: A Decision Framework [2012]

Philippines

• BMC Public Health
  • A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines [2015]

• Cost Effectiveness and Resource Allocation
  • Incorporating economies of scale in the cost estimation in economic evaluation of PCV and HPV vaccination programmes in the Philippines: a game changer? [2018]

Republic of Korea

• Journal of Gynecologic Oncology
  • Clinical guideline for 9-valent HPV vaccine: Korean Society of Gynecologic Oncology Guideline [2019]
  • Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline [2016]

Rwanda

• Bulletin of the World Health Organization
  • Achieving high coverage in Rwanda's national human papillomavirus vaccination programme [2012]

South Africa

• BMC Infectious Diseases
  • Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence [2015]

Spain

• EuroSurveillance
  • Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016 [2019]

Sub-Saharan Africa

• PLoS ONE
  • Knowledge and Awareness of HPV Vaccine and Acceptability to Vaccinate in Sub-Saharan Africa: A Systematic Review [2014]

Switzerland

• BMC Infectious Diseases
  • Impact of HPV vaccination with Gardasil® in Switzerland [2017]

Tanzania

• Health Policy and Planning
  • Feasibility and acceptability of delivering adolescent health interventions alongside HPV vaccination in Tanzania [2016]

Uganda

• Infectious Agents and Cancer
  • Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review [2011]

• Vaccine
  • Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country [2018]

United Kingdom

• BMC Infectious Diseases
  • Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK [2019]

• BMJ
  • Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study [2019]

• HSC Public Health Agency
  • Human papillomavirus (HPV) immunisation programme - Factsheet for healthcare professionals [2018]

• Human Vaccines & Immunotherapeutics
  • Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom [2015]

• ISD Scotland
  • HPV Immunisation Statistics Scotland [2016]

• PLoS ONE
  • HPV Serology Testing Confirms High HPV Immunisation Coverage in England [2016]

• Public Health England
  • Human papillomavirus (HPV)
  • HPV vaccination programme
  • HPV vaccination and cervical cancer: addressing the myths

• Vaccine
  • Risk of spontaneous abortion and other pregnancy outcomes in 15–25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom [2015]

United States of America

• American Cancer Society
  • Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement [2016]

• American College of Obstetricians and Gynecologists
  • Human Papillomavirus Vaccination [2017]

• American Society of Clinical Oncology
  • Recommendations for 2-Dose HPV Vaccination Schedule [2016]
  • American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention [2016]

• BMC Pediatrics
  • Factors associated with parental reasons for “no-intent” to vaccinate female adolescents with human papillomavirus vaccine: National Immunization Survey - Teen 2008–2012 [2017]

• Centers for Disease Control and Prevention
  • Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices [2019]
  • Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices [2016]
  • Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices [2015]
  • Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans — United States, 2013 [2015]
  • National Human Papillomavirus Vaccination Coverage Among Adolescents Aged 13–17 Years — National Immunization Survey – Teen, United States, 2011 [2014]
  • Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2014]
  • Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States [2014]
  • CDC Grand Rounds: Reducing the Burden of HPV-Associated Cancer and Disease [2014]
  • Vaccination Schedules and Recommendations
  • Surveillance Manual | HPV
  • Human Papillomavirus (HPV) Vaccine Safety
  • HPV Vaccination | For Providers
  • HPV Vaccination Coverage

• Food and Drug Administration
  • Gardasil

• Frontiers in Oncology
  • Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination [2016]

• Human Vaccines & Immunotherapeutics
  • Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule [2015]

• Minnesota Department of Health
  • Human Papilloma Virus (HPV) Vaccine

• National Cancer Institute
  • Human Papillomavirus (HPV) Vaccines

• Obstetrics & Gynecology Clinics of North America
  • Human Papillomavirus Vaccination: Current Indications and Future Directions [2013]

• Society for Adolescent Health and Medicine
  • Human Papillomavirus (HPV) Vaccine: A Position Statement of the Society for Adolescent Medicine [2006]

• Vaccine
  • Primary care providers human papillomavirus vaccine recommendations for the medically underserved: A pilot study in U.S. Federally Qualified Health Centers [2014]

WHO

• World Health Organization
  • Human Papillomavirus (HPV) position paper [2017]
  • Scaling-up HPV vaccine introduction [2016]
  • HPV vaccine communication: special considerations for a unique vaccine. 2016 update [2016]
  • Guide to introducing HPV vaccine into national immunization programmes [2016]
  • Options for linking health interventions for adolescents with HPV vaccination [2014]
  • Report of the HPV vaccine delivery meeting [2012]
  • The immunological basis for immunization series: module 19: human papillomavirus infection [2011]
  • Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland [2010]
  • Cervical cancer, human papillomavirus (HPV) and HPV vaccines : key points for policy-makers and health professionals [2007]
  • Preparing for the introduction of HPV vaccines: policy and programme guidance for countries [2006]
  • Guidelines to assure the Quality, safety and efficacy of recombinant Human Papillomavirus virus-like particle vaccines, ECBS 2006 [2006]
  • WHO HPV Laboratory Network

Zimbabwe

• Bulletin of the World Health Organization
  • Cost of a human papillomavirus vaccination project, Zimbabwe [2018]

• Infectious Agents and Cancer
  • Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe [2014]

{Related topics}

• Guidelines
  • Cervical cancer